Patent
   D370726
Priority
May 24 1994
Filed
Nov 22 1994
Issued
Jun 11 1996
Expiry
Jun 11 2010
Assg.orig
Entity
unknown
41
7
n/a
The ornamental design for a cap for an inhalation device, as shown and described.

FIG. 1 is a bottom, right perspective view of a cap for an inhalation device showing my new design;

FIG. 2 is a bottom plan view thereof;

FIG. 3 is a top plan view thereof;

FIG. 4 is a left elevational view thereof;

FIG. 5 is a front elevational view thereof; and,

FIG. 6 is a rear elevational view thereof.

The broken line showing of environment in all views is for illustrative purposes only and forms no part of the claimed design.

Padfield, John M.

Patent Priority Assignee Title
D395147, Aug 19 1996 Orion Corporation Combined inhaler and cover
D433502, Jan 29 1999 Glaxo Wellcome Inc Inhalation device
D439325, Feb 08 2000 IVAX RESEARCH, INC Cover for a nasal inhaler
D478982, Apr 09 2002 SmithKline Beecham Corporation Actuator strap cap
D598536, Nov 23 2006 Innovata Biomed Limited Inhaler
D639931, Sep 14 2006 Glaxo Group Limited Inhaler
D653326, Sep 14 2006 Glaxo Group Limited Inhaler
D653327, Mar 12 2007 Glaxo Group Limited Inhaler
D653747, Sep 14 2006 Glaxo Group Limited Inhaler
D666096, Nov 01 2010 Colgate-Palmolive Company Cap for a container
D666097, Nov 01 2010 Colgate-Palmolive Company Cap for a container
D666098, Nov 01 2010 Colgate-Palmolive Company Cap for a container
D666099, Nov 01 2010 Colgate-Palmolive Company Cap for a container
D666492, Nov 01 2010 Colgate-Palmolive Company Cap for a container
D666493, Nov 01 2010 Colgate-Palmolive Company Cap for a container
D782647, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782648, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782649, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782650, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782651, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782652, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D782653, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783147, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory appartus
D783148, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783149, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783150, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783151, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783152, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783153, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783154, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783155, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783156, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783157, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783158, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783159, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783804, Oct 08 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783805, Jul 10 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783806, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D783807, Oct 07 2013 TEVA Pharmaceutical Industries Limited Respiratory apparatus
D856659, Jun 26 2018 Inhaler cover
D901671, Nov 28 2018 RPC Formatec GmbH Inhaler
Patent Priority Assignee Title
2745402,
206979,
220805,
237017,
D311443, Feb 23 1987 GLAXO GROUP LIMITED, CLARGES HOUSE, 6 12 CLARGES STREET, LONDON W1Y 8DH, ENGLAND, A BRITISH COMPANY Inhalator
D348929, Apr 03 1992 Norton Healthcare Limited Medicament inhaler
D349522, May 14 1992 Game board
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Nov 22 1994Glaxo Group Limited(assignment on the face of the patent)
Dec 15 1994PADFIELD, JOHN MALCOLMGlaxo Group LimitedASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0073100622 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule